Skip to main content

Table 1 Baseline characteristics of the 54 patients

From: Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment

Characteristics Baseline value
 Age, years 60 (36–84)
 Sex, n (%) female 42 (78)
Disease status
 Disease duration, years 16 (1–36)
 Disease Activity Score in 28 joints-erythrocyte sedimentation rate 5.3 (2.1–7.7)
 Erythrocyte sedimentation rate, mm/h 33.4 (3.0–111.0)
 C-reactive protein, mg/L 17 (1–166)
 Rheumatoid factor positivity, n (%) 38 (70)
 Anti-cyclic citrullinated peptide positivity, n (%) 47 (87)
 Radiologic evidence of erosions, n (%) 42 (78)
Previous treatment, n (%)
 Anti-tumor necrosis factor-α 42 (78)
 Methotrexate 24 (52)
 Prednisone 42 (78)
Lymphocyte immunophenotype
 CD19+ cells/mm3 211 (25–706)
 CD3+ cells/mm3 1,740 (323–3,378)
 CD4+ cells/mm3 1,192 (233–2,882)
 CD8+ cells/mm3 482 (120–1,114)
  1. Values are the median (min–max) unless stated otherwise